AI assistant
PLUS THERAPEUTICS, INC. — Director's Dealing 2025
Oct 3, 2025
34301_dirs_2025-10-03_b86aa652-24bc-411c-8b7a-690ebb5fd618.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: PLUS THERAPEUTICS, INC. (PSTV)
CIK: 0001095981
Period of Report: 2025-08-13
Reporting Person: Sims Andrew John Hugh MacIntyre (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-08-13 | Stock Option (Right to Buy) | $0.5744 | A | 1379636 | Acquired | 2035-08-12 | Common Stock (1379636) | Direct |
| 2025-08-13 | Restricted Stock Units | $ | A | 459878 | Acquired | Common Stock (459878) | Direct |
Footnotes
F1: The options vest over four years in equal 1/48th increments on each monthly anniversary of the issuance.
F2: This amendment is being filed to correct a Form 4 filed on August 15, 2025, which inadvertently disclosed the incorrect vesting terms of the Restricted Stock Units ("RSUs"). The RSUs awarded on August 13, 2025 vest over twelve quarters, vesting in substantially equal 1/12th increments beginning with the quarter ended September 30, 2025. The RSUs convert into shares of Common Stock upon vesting on a one for one basis.